Beta test of equity app for acute leukemia patients
Part of Blood & lymphatic, Cancer clinical trials.
This study is beta-testing a new app designed to reduce healthcare disparities among people admitted to the hospital with suspected acute leukemia. Your feedback could help make the app more helpful for future patients.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years old or older.
- You speak English.
- Your doctor suspects you may have acute leukemia (a rapid-growing blood cancer).
- You are currently admitted to a Dana-Farber Cancer Institute or affiliated hospital inpatient unit.
- You have not already taken part in the earlier testing phase of this study (alpha testing).
- You are able to use a tablet or smartphone application in person without help from a caregiver.
- You do not have significant cognitive impairment (like trouble understanding or communicating) that would make it hard to test the app.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests an emotion- and symptom-focused way of engaging with care for people who are newly diagnosed with acute leukemia and starting intensive “induction” treatment aimed at cure. It may help you feel better supported and better able to manage distressing symptoms during a critical early phase of treatment.
This study tests whether a formal support program can help people newly diagnosed with acute leukemia. If you're starting treatment at the Centre Henri Becquerel, this program may offer extra guidance and help improve your quality of life.
This study tests a digital application to help patients with acute myeloid leukemia (AML) during their hospital stay. It may assist with tracking symptoms, education, or communication with care teams.
This trial studies how screening for social needs (like housing, food, or transportation) and offering early help can improve care for adults with leukemia. It is for patients newly referred to a leukemia clinic.
This study checks how well remote (at-home) symptom check-ins work for people with certain cancers. It may help patients and clinicians spot problems earlier and improve day-to-day care during treatment and beyond.
This trial tests whether using a mobile app to track daily medication and weekly blood tests can help children with acute lymphoblastic leukemia (ALL) continue maintenance therapy safely at home, without needing to stay in the hospital.
Hear when a new Acute Leukemia trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.